Amanote Research

Amanote Research

  • Register
  • Sign In

Does mIDH Inhibitors Is a Promising Therapy?

Biomedical Journal of Scientific & Technical Research

doi 10.26717/bjstr.2017.01.000197

Full Text

Abstract

Available in

Date

July 18, 2017

Authors

Nahla A M Hamed

Publisher

Biomedical Research Network, LLC


Related search

Preclinical Studies Reveal MLN4924 Is a Promising New Retinoblastoma Therapy

Cell Death Discovery
Cancer ResearchMolecular NeuroscienceImmunologyCell BiologyCellular
2020English

Proteinase Inhibitors: A Promising Drug Class for Treating Leishmaniasis

Current Drug Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2014English

Osteopontin -- A Promising Biomarker for Cancer Therapy

Journal of Cancer
Oncology
2017English

Akkermansia Muciniphila Is a Promising Probiotic

Microbial Biotechnology
Applied MicrobiologyBiotechnologyBiochemistryBioengineering
2019English

Inflammasome Inhibitors: Promising Therapeutic Approaches Against Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Aptamers: A Promising Chemical Antibody for Cancer Therapy

Oncotarget
Oncology
2016English

Gene Therapy: A Promising Therapeutic Strategy for Malaria

University of Ottawa Journal of Medicine
2018English

Differentiation Therapy: A Promising Strategy for Cancer Treatment

Chinese Journal of Cancer
2016English

Eluxadoline: A Promising Therapy That Raises Many Questions

Translational Gastroenterology and Hepatology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote


© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy